Biggest Industry Ups And Downs Of 2011 February 06, 2012

New Post Public Reply Private Reply Replies (0) Message Board
NITE

Biggest Industry Ups And Downs Of 2011
February 06, 2012 | Filed Under » Bear Market, Bull Market, Economy, Investing Basics

2011 was an eventful year for the American economy, and it seems to be slowly getting back on track. The last few weeks of 2011 started seeing some positive activity in consumer spending. Banking is slowly recovering, as is the demand for cars. Employment opportunities have improved with unemployment down to 8.5%. However, it was a recession-hit year for the economy, with greater focus on creating higher consumption through greater government spending.

SEE: Consumer Spending As A Market Indicator

According to the Chief Financial Officer of Washington DC, Natwar Gandhi, "There is no consumer demand as we speak. The businesses are not investing, as they do not see any demand out there. So the only player who can really generate demand is government. The government needs to spend money. There is a need to spend money on our infrastructure, which is abysmal. Unless government spends money to generate demand, I see very likely a lost decade, the kind that the Japanese have experienced over the last 10 years."
Let's take a look at the industries that performed the best and the worst in the year 2011. We will keep the Standard and Poor's (S&P) index as the benchmark to understand the American economy better. This index covers about 500 large cap American companies, and is considered to be a good indicator of the American economy. Our analysis is based on the Select Sector SPDRs, which are ETFs that divide the S&P 500 into nine sector index funds.The following table provides a snapshot of how each of the industry funds performed during the year 2011.

Total Returns (Net Asset Value) as of Dec. 31, 2011
SPDR Fund Select Sector Year 2011
Utilities 19.51%
Cons Staples 14.00%
Health Care 12.42%
Cons Discretionary 5.95%
Energy 2.98%
Technology 2.67%
Industrials -1.02%
Materials -10.97%
Financials -17.16%
The Biggest Rises
As you can see, the four industries that significantly outperformed the S&P500 index are: utilities, consumer staples, healthcare, and consumer discretionary. (For additional reading, check out Is Your Portfolio Beating Its Benchmark?)

Let's take a brief look at each of these industries.

Utilities: These are the companies that produce, generate, transmit or distribute electricity or natural gas. Utilities sector was the star performer in 2011. The key factor driving growth in this sector is the increased demand of electricity. The utility stocks offer relative safety and stability, and this could have been the reason behind investor attraction, due to the global financial crisis and European debt woes.

Consumer Staples: This sector includes companies that are primarily involved in consumer products, food and beverages, retail drugs, fast moving consumer goods, household products and personal care. The Consumer Staples Select Sector SPDR Fund showed a 14% increase in the year 2011. This sector has a demand that is non-cyclical. The growth has been consistent, even though the year saw high fuel volatility, which pushed up the prices of food. (To learn more, read Cyclical Versus Non-Cyclical Stocks.)
Penny stocks are the secret to 2000%+ profits!
Healthcare: This sector includes companies making healthcare equipment and supplies, healthcare providers and services, biotechnology and pharmaceuticals industries. Expenditure on healthcare is expected to reach 31% of GDP by 2035, according to the Congressional Budget Office. About 17% of the population is still uninsured; this is expected to come down to 5% if the government goes ahead with its proposed plans for healthcare. According to PricewaterhouseCoopers, the key drivers for growth in the healthcare sector have been consolidation of providers, increased demand for healthcare due to stress related-diseases and cost shifting from Medicare and Medi-aid.

Consumer Discretionary: This includes automobiles, consumer durables, apparel, hotels, media and retail industries.Renewed consumer confidence in the U.S. auto sector has seen it on a resurgent mode. U.S. light-vehicle deliveries climbed 10%, or about 1.19 million, to 12.8 million in 2011. It is expected to grow further in 2012. The stocks in the consumer discretionary sector have performed better than high investment sectors like construction. This sector does have some cyclical nature, but lowering unemployment rates mean the outlook for 2012 is also positive.

The Biggest Falls
The two industries that did worst in 2011 were: Financial and Materials.

Financials: This was the worst performing sector in 2011. The Financials Select Sector SPDR Funddropped by as much as 17% during the year. In addition to the slowing economy, Basel III's stricter capital adequacy norms, stricter government regulations and high default by consumers all further put pressure on the financial sector. This was further compounded by the problems in Europe.

Materials: This sector includes companies in chemicals, construction materials, containers and packaging, metals and mining, and paper and forest products. The sector saw a dip, as there was little to no demand for housing and infrastructure. Sluggish demand and increased cost of materials saw this sector facing a low. Global outlook of demand for materials is currently on the downside.
The Bottom Line
The other sectors - technology, industrials, and energy - showed little or no growth. All in all it was a lackluster year for the U.S. economy. The last quarter of 2011 saw demand slowly rising and unemployment levels falling, and the government is planning to invest in the system. The growth prediction for 2012 is 3%, slightly better than 0.9% growth of the first two quarters of 2011. Clearly, the improvements are coming in a trickle, but they are improvements nevertheless.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading

Top 5 Most Recently Viewed Articles

U Power Limited Advances Electric Vehicle Solutions in Europe

Updated Category News Views 239

U Power Limited Expands Its European Reach U Power Limited (Nasdaq: UCAR) is making significant strides in the electric vehicle (EV) landscape. The company, known for its innovative battery-swapping technology, has announced an exciting joint venture that enhances their presence in the European market. This strategic move is expected to reshape how electric mobility is...

Continue Reading
UKG Stands Out as a Top Leader in Workforce Management Solutions

Updated Category News Views 163

UKG Secures Top Spot in Workforce Management UKG, a leading provider in HR, payroll, workforce management, and cultural solutions, has recently earned recognition for its exceptional contributions to the workforce management field. The company has been named a Leader in the NelsonHall New World Workforce Management 2024 evaluation, showcasing its strong performance across...

Continue Reading
Prominent Movers in Today's Market: Micron, Accenture Rise

Updated Category News Views 141

As the trading day unfolds, the US stock market is witnessing a shift, with several companies experiencing significant movements in their stock prices. Recent trends show that investors are closely monitoring the market after a minor disruption in gains. Micron's Robust Performance Micron Technology (NASDAQ: MU) has captured the spotlight today, with shares surging by an...

Continue Reading
Celebrate 1.5 Years of Obey Me! Nightbringer with Exciting Events

Updated Category News Views 85

Celebrating 1.5 Years of Obey Me! Nightbringer Obey Me! Nightbringer is reaching a significant milestone, celebrating its 1.5-year anniversary. This beloved mobile game from NTT Solmare has captured the hearts of players around the globe, and to acknowledge this momentous occasion, the developers are rolling out a variety of exciting events. Four Exciting Events for...

Continue Reading
Celebrating Innovation: 2026 sofi™ Awards Winners Unveiled

Updated Category News Views 219

Celebrating Culinary Excellence: The 2026 sofi™ Awards NEW YORK — The Specialty Food Association (SFA) revealed the much-anticipated results of the 2026 sofi™ Awards at the Winter FancyFaire event. This celebrated gathering brought together industry leaders, chefs, makers, and buyers to applaud the finest in specialty food and beverage innovation. A Night of...

Continue Reading